Oral Oresentation 3

2:18 PM - 2:24 PM JST(5:18 AM - 5:24 AM UTC)

[O03-04] High clinical and endoscopic remission rate with Vedolizumab in early CD patients: the 2nd interim analysis from a prospective multicenter interventional study (EARLY CD)

*Jing Liu^1,2, Hong Guo³, Yuqin Li⁴, Liangru Zhu ⁵, Yan Jia⁶, Hongjie Zhang⁷, Heng Zhang⁸, Qin Huang^9,10, Xiang Gao¹¹, Qian Cao^1,2 (1. Sir Run Run Shaw Hospital- Zhejiang University School of Medicine, Department of Gastroenterology, Hangzhou, China., 2. Sir Run Run Shaw Hospital- Zhejiang University School of Medicine, Inflammatory Bowel Disease Center, Hangzhou, China., 3. Chongqing General Hospital- Chongqing University, Department of Gastroenterology, Chongqing, China., 4. First Hospital of Jilin University, Department of Gastroenterology, Changchun, China., 5. Union Hospital- Tongji Medical College- Huazhong University of Science and Technology, Department of Gastroenterology, Wuhan, China., 6. Seventh Medical Center of PLA General Hospital, Department of Gastroenterology, Beijing, China., 7. The First Affiliated Hospital with Nanjing Medical University, Department of Gastroenterology, Nanjing, China., 8. The Central Hospital of Wuhan- Tongji Medical College- Huazhong University of Science and Technology, Department of Gastroenterology, Wuhan, China., 9. Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Department of Gastroenterology, Taizhou, China., 10. Enze Hospital-Taizhou Enze Medical Center Group, Department of Gastroenterology, Taizhou, China., 11. The Sixth Affiliated Hospital of Sun Yat-sen University, Department of Gastroenterology, Guangzhou, China.)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.